Chae Young Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chae Young Lee has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Eun-Jin Kim
Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea
6 shared publications - Il-Hwan Kim
Division of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungbuk, Republic of Korea
6 shared publications - Ae Kyung Park
Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea
4 shared publications - Jee Eun Rhee
Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea
4 shared publications - Jeong-Min Kim
Korea Disease Control and Prevention Agency
4 shared publications - Jin Sun No
Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea
4 shared publications
Latest Publications
- Open Access
Long-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants
Since the onset of the COVID-19 pandemic, the Republic of Korea has experienced continuous waves of SARS-CoV-2 variants. The current study aimed to analyze the long-term trends of variant prevalence and associated changes in immune responses within the country. Whole-genome sequencing was performed on confirmed patient samples collected from December 2020 to May 2025, and variant distribution, genetic diversity, and neutralization were compared. As a result of analyzing a total of 157,962 gene sequences, various Omicron sub-lineages, including BA.1, BA.2, BA.5, followed by JN.1, KP.3, and NB.1.8.1, were seen to circulate sequentially over time. The nucleotide diversity of the SARS-CoV-2 genome gradually increased after the JN.1 outbreak. Of the tested variants, hamster antiserum neutralization analysis indicated that Omicron NB.1.8.1, which began to circulate in 2025, exhibited the lowest neutralization activity, with an approximately 6.6-fold decrease compared to JN.1. This suggests a potential expansion in the dominance of new variants with enhanced immune evasion. As the transmission of SARS-CoV-2 continues, new variants with novel characteristics may emerge; therefore, continuous national genomic surveillance and immunological characterization are considered crucial for early detection of emerging variants and for guiding effective public health responses.
Open AccessLong-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants
Since the onset of the COVID-19 pandemic, the Republic of Korea has experienced continuous waves of SARS-CoV-2 variants. The current study aimed to analyze the long-term trends of variant prevalence and associated changes in immune responses within the country. Whole-genome sequencing was performed on confirmed patient samples collected from December 2020 to May 2025, and variant distribution, genetic diversity, and neutralization were compared. As a result of analyzing a total of 157,962 gene sequences, various Omicron sub-lineages, including BA.1, BA.2, BA.5, followed by JN.1, KP.3, and NB.1.8.1, were seen to circulate sequentially over time. The nucleotide diversity of the SARS-CoV-2 genome gradually increased after the JN.1 outbreak. Of the tested variants, hamster antiserum neutralization analysis indicated that Omicron NB.1.8.1, which began to circulate in 2025, exhibited the lowest neutralization activity, with an approximately 6.6-fold decrease compared to JN.1. This suggests a potential expansion in the dominance of new variants with enhanced immune evasion. As the transmission of SARS-CoV-2 continues, new variants with novel characteristics may emerge; therefore, continuous national genomic surveillance and immunological characterization are considered crucial for early detection of emerging variants and for guiding effective public health responses.
- Open Access
- 13 December 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 44 (3) , 289-293
Neutralization Testing–based Immunogenicity Analysis of Recent Prevalent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Sublineages
Eun Ju Lee, M.S., Hyeokjin Lee, M.S., Sang Won O, M.S., Jee Eun Rhee, Ph.D., Jeong-Min Kim, Ph.D., Dong Ju Kim, M.S., Il-Hwan Kim, Ph.D., Jin Sun No, Ph.D., Ae Kyung Park, Ph.D., Jeong-Ah Kim, Ph.D., Chae Young Lee, B.S., Young-Ki Choi, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2024;44:289-93. https://doi.org/10.3343/alm.2023.0256
- 13 December 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 44 (3) , 289-293
Open AccessNeutralization Testing–based Immunogenicity Analysis of Recent Prevalent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Sublineages
Eun Ju Lee, M.S., Hyeokjin Lee, M.S., Sang Won O, M.S., Jee Eun Rhee, Ph.D., Jeong-Min Kim, Ph.D., Dong Ju Kim, M.S., Il-Hwan Kim, Ph.D., Jin Sun No, Ph.D., Ae Kyung Park, Ph.D., Jeong-Ah Kim, Ph.D., Chae Young Lee, B.S., Young-Ki Choi, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2024;44:289-93. https://doi.org/10.3343/alm.2023.0256
- Open Access
- 31 August 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (4) , 272-278
Increased viral load in patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in the Republic of Korea
Objectives: Coronavirus disease 2019 (COVID-19) has been declared a global pandemic owing to the rapid spread of the causative agent, severe acute respiratory syndrome coronavirus 2. Its Delta and Omicron variants are more transmissible and pathogenic than other variants. Some debates have emerged on the mechanism of variants of concern. In the COVID-19 wave that began in December 2021, the Omicron variant, first reported in South Africa, became identifiable in most cases globally. The aim of this study was to provide data to inform effective responses to the transmission of the Omicron variant.Methods: The Delta variant and the spike protein D614G mutant were compared with the Omicron variant. Viral loads from 5 days after symptom onset were compared using epidemiological data collected at the time of diagnosis.Results: The Omicron variant exhibited a higher viral load than other variants, resulting in greater transmissibility within 5 days of symptom onset.Conclusion: Future research should focus on vaccine efficacy against the Omicron variant and compare trends in disease severity associated with its high viral load.
- 31 August 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (4) , 272-278
Open AccessIncreased viral load in patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in the Republic of Korea
Objectives: Coronavirus disease 2019 (COVID-19) has been declared a global pandemic owing to the rapid spread of the causative agent, severe acute respiratory syndrome coronavirus 2. Its Delta and Omicron variants are more transmissible and pathogenic than other variants. Some debates have emerged on the mechanism of variants of concern. In the COVID-19 wave that began in December 2021, the Omicron variant, first reported in South Africa, became identifiable in most cases globally. The aim of this study was to provide data to inform effective responses to the transmission of the Omicron variant.Methods: The Delta variant and the spike protein D614G mutant were compared with the Omicron variant. Viral loads from 5 days after symptom onset were compared using epidemiological data collected at the time of diagnosis.Results: The Omicron variant exhibited a higher viral load than other variants, resulting in greater transmissibility within 5 days of symptom onset.Conclusion: Future research should focus on vaccine efficacy against the Omicron variant and compare trends in disease severity associated with its high viral load.
- Open Access
- 25 October 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (2) , 211-213
Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
Ae Kyung Park, Ph.D., Il-Hwan Kim, Ph.D., Chae Young Lee, B.S., Jeong-Ah Kim, Ph.D., Hyeokjin Lee, M.S., Heui Man Kim, Ph.D., Nam-Joo Lee, M.S., SangHee Woo, M.S., Jaehee Lee, B.S., JeeEun Rhee, Ph.D., Cheon-Kwon Yoo, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2023;43:211-3. https://doi.org/10.3343/alm.2023.43.2.211
- 25 October 2022
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (2) , 211-213
Open AccessRapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
Ae Kyung Park, Ph.D., Il-Hwan Kim, Ph.D., Chae Young Lee, B.S., Jeong-Ah Kim, Ph.D., Hyeokjin Lee, M.S., Heui Man Kim, Ph.D., Nam-Joo Lee, M.S., SangHee Woo, M.S., Jaehee Lee, B.S., JeeEun Rhee, Ph.D., Cheon-Kwon Yoo, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2023;43:211-3. https://doi.org/10.3343/alm.2023.43.2.211
- Open Access
- 28 February 2021
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 12 (1) , 37-43
Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020
Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.
- 28 February 2021
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 12 (1) , 37-43
Open AccessGenomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020
Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.